Insys Therapeutics beats by $0.28, beats on revenue

Insys Therapeutics (NASDAQ:INSY): Q2 EPS of $0.58 beats by $0.28.

Revenue of $55.7M (+196.0% Y/Y) beats by $2.93M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs